Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11839404rdf:typepubmed:Citationlld:pubmed
pubmed-article:11839404lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:11839404lifeskim:mentionsumls-concept:C0017296lld:lifeskim
pubmed-article:11839404lifeskim:mentionsumls-concept:C0596972lld:lifeskim
pubmed-article:11839404lifeskim:mentionsumls-concept:C0009393lld:lifeskim
pubmed-article:11839404lifeskim:mentionsumls-concept:C0554756lld:lifeskim
pubmed-article:11839404lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:11839404lifeskim:mentionsumls-concept:C1521743lld:lifeskim
pubmed-article:11839404lifeskim:mentionsumls-concept:C0181904lld:lifeskim
pubmed-article:11839404lifeskim:mentionsumls-concept:C1704646lld:lifeskim
pubmed-article:11839404lifeskim:mentionsumls-concept:C0728873lld:lifeskim
pubmed-article:11839404pubmed:issue12lld:pubmed
pubmed-article:11839404pubmed:dateCreated2002-2-12lld:pubmed
pubmed-article:11839404pubmed:abstractTextUsing contrast-enhanced color Doppler (CD) sonography, we assessed alterations of tumor blood flow induced in 25 murine Morris hepatomas transfected with a gancyclovir- (GCV-)sensitizing Herpes simplex virus thymidine kinase (HSVtk) suicide gene in combination with systemic GCV treatment and compared findings with a control tumor. CD measurements were quantified by the color pixel density (CPD) and the mean encoded flow velocity (mean color value, MCV), using computer-assisted image analysis, and compared with histologic arteriole counts. During 5 days, the tumor volume remained constant. In HSVtk-expressing tumors, the median CPD dropped from 16% at baseline to 5% on day 5 (p = 0.001), remaining constant in controls. The MCV decreased from 1.9 cm/s to 1.6 cm/s in the HSVtk-expressing tumors (p = 0.001) and rose from 1.8 cm/s to 2.0 cm/s in the controls (p = 0.002). In an accompanying histologic arteriole assay, we found no alterations attributable to treatment.lld:pubmed
pubmed-article:11839404pubmed:languageenglld:pubmed
pubmed-article:11839404pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11839404pubmed:citationSubsetIMlld:pubmed
pubmed-article:11839404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11839404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11839404pubmed:statusMEDLINElld:pubmed
pubmed-article:11839404pubmed:monthDeclld:pubmed
pubmed-article:11839404pubmed:issn0301-5629lld:pubmed
pubmed-article:11839404pubmed:authorpubmed-author:van KaickGGlld:pubmed
pubmed-article:11839404pubmed:authorpubmed-author:HaberkornUUlld:pubmed
pubmed-article:11839404pubmed:authorpubmed-author:ZunaIIlld:pubmed
pubmed-article:11839404pubmed:authorpubmed-author:DelormeSSlld:pubmed
pubmed-article:11839404pubmed:authorpubmed-author:BahnerM LMLlld:pubmed
pubmed-article:11839404pubmed:authorpubmed-author:KinscherfRRlld:pubmed
pubmed-article:11839404pubmed:issnTypePrintlld:pubmed
pubmed-article:11839404pubmed:volume27lld:pubmed
pubmed-article:11839404pubmed:ownerNLMlld:pubmed
pubmed-article:11839404pubmed:authorsCompleteYlld:pubmed
pubmed-article:11839404pubmed:pagination1595-603lld:pubmed
pubmed-article:11839404pubmed:dateRevised2006-4-21lld:pubmed
pubmed-article:11839404pubmed:meshHeadingpubmed-meshheading:11839404...lld:pubmed
pubmed-article:11839404pubmed:meshHeadingpubmed-meshheading:11839404...lld:pubmed
pubmed-article:11839404pubmed:meshHeadingpubmed-meshheading:11839404...lld:pubmed
pubmed-article:11839404pubmed:meshHeadingpubmed-meshheading:11839404...lld:pubmed
pubmed-article:11839404pubmed:meshHeadingpubmed-meshheading:11839404...lld:pubmed
pubmed-article:11839404pubmed:meshHeadingpubmed-meshheading:11839404...lld:pubmed
pubmed-article:11839404pubmed:meshHeadingpubmed-meshheading:11839404...lld:pubmed
pubmed-article:11839404pubmed:meshHeadingpubmed-meshheading:11839404...lld:pubmed
pubmed-article:11839404pubmed:meshHeadingpubmed-meshheading:11839404...lld:pubmed
pubmed-article:11839404pubmed:meshHeadingpubmed-meshheading:11839404...lld:pubmed
pubmed-article:11839404pubmed:meshHeadingpubmed-meshheading:11839404...lld:pubmed
pubmed-article:11839404pubmed:meshHeadingpubmed-meshheading:11839404...lld:pubmed
pubmed-article:11839404pubmed:meshHeadingpubmed-meshheading:11839404...lld:pubmed
pubmed-article:11839404pubmed:meshHeadingpubmed-meshheading:11839404...lld:pubmed
pubmed-article:11839404pubmed:meshHeadingpubmed-meshheading:11839404...lld:pubmed
pubmed-article:11839404pubmed:year2001lld:pubmed
pubmed-article:11839404pubmed:articleTitleChanges of tumor vascularity during gene therapy monitored with color Doppler US.lld:pubmed
pubmed-article:11839404pubmed:affiliationGerman Cancer Research Center (DKFZ), Department of Oncological Diagnostics and Therapy, Im Neuenheimer Feld 280, D 69120 Heidelberg, Germany. s.delorme@dkfz.delld:pubmed
pubmed-article:11839404pubmed:publicationTypeJournal Articlelld:pubmed